Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06203132 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

DORAvirine Versus DOlutegravir Based Antiretroviral Regimens in Treatment-naïve People Living With HIV-1 Infection

Study acronym: ELDORADO
StatusRecruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 1 year 1 month later Nov 2026 → Jan 2028
See other at-risk trials from ANRS, Emerging Infectious Diseases

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion pushed from Nov 2026 to Jan 2028
    • Study completion pushed from Nov 2027 to Jan 2029
    • Site details revised at 4 of 19 sites
    v7
  2. Secondary endpoints expanded, about 351 wordsv6
  3. Site details revised at 4 of 19 sitesv5
  4. Site details revised at 3 of 19 sitesv4
  5. Trial status: Not Yet Recruiting to Recruitingv3 Show 5 more changesShow less
    • Primary endpoint revised
    • Study sites: 6 to 19
    • Start date changed from estimate of Nov 2024 to Jan 27, 2025
    • Study description revised
    • Collaborators: 1 to 2
  6. Primary completion date: Apr 2026 to Nov 2026
    • Start date: Apr 2024 to Nov 2024
    • Study completion date: Apr 2027 to Nov 2027
    • Eligibility criteria shortened, about 50 words
    v2
  7. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Phase III trial evaluating doravirine as an alternative to dolutegravir in treatment naïve people living with HIV-1 infection.
Trial Details
NCT Number NCT06203132
Lead Sponsor ANRS, Emerging Infectious Diseases
Collaborators: MSD France, European and Developing Countries Clinical Trials Partnership (EDCTP)
Conditions
(from sponsor)		 HIV-1-infection
Enrollment 610 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov